Novel endpoints and design of early clinical trials
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/13/suppl_4/139/418301/mdf651.pdf
Reference22 articles.
1. New guidelines to evaluate the response to treatment in solid tumors;Therasse;J Natl Cancer Inst,2000
2. Handbook for Reporting Results of Cancer Treatment, World Health Organization Offset Publication No. 48,1979
3. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer;Thalmann;J Natl Cancer Inst,1996
4. Development of target-based antineoplastic agents;Stadler;Invest New Drugs,2000
5. Application of a new multinomial phase II stopping rule using response and early progression;Dent;J Clin Oncol,2001
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Methodological studies;Principles of Translational Science in Medicine;2021
2. PET/Computed Tomography in Treatment Response Assessment in Cancer;PET Clinics;2020-01
3. Response assessment of bone metastatic disease: seeing the forest for the trees RECIST, PERCIST, iRECIST, and PCWG-2;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2019-09
4. Increasing complexity in oncology phase I clinical trials;Investigational New Drugs;2018-11-16
5. Clinical Trial Design and Implementation in Neuro-Oncology;Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3